Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 211-213, 2004; 10.1373/clinchem.2003.026914
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, M.
Right arrow Articles by Su, Y.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, M.
Right arrow Articles by Su, Y.-H.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2004;50:211-213.)
© 2004 American Association for Clinical Chemistry, Inc.

Technical Briefs

Preferential Isolation of Fragmented DNA Enhances the Detection of Circulating Mutated k-ras DNA

Mengjun Wang1, Timothy M. Block1, Laura Steel1, Dean E. Brenner2 and Ying-Hsiu Su1,a

1 Department of Biochemistry and Molecular Pharmacology Jefferson Center for Biomedical Research, Thomas Jefferson University, 700 E. Butler Ave., Doylestown, PA 18901
2 Departments of Internal Medicine and Pharmacology, 2150B Cancer and Geriatrics Center, University of Michigan Medical Center, Ann Arbor, MI

aauthor for correspondence: fax 215-489-4920, e-mail Yinghsiu.Su@jefferson.edu

The first 20% of the full text of this article appears below.

In the course of studying the incidence of k-ras mutations in DNA in the circulation of patients with colorectal disease, we observed that our ability to detect mutated k-ras DNA in serum varied with the method of DNA isolation. Two methods of DNA isolation were used in this study. One was the QIAamp DNA Blood Midi Kit (Qiagen, Inc.), which has been widely used for isolating circulating DNA from serum or plasma (1)(2)(3)(4)(5). The other is the modified Guanidine/Promega Resin (G/R) method that was developed to isolate DNA from urine (6).

To compare the applicability of the Qiagen and G/R methods for isolation of circulating DNA, we purified DNA from aliquots of serum from six patients with known mutant k-ras-positive colorectal disease (colorectal cancer or adenomatous polyps) and analyzed it for the presence of mutated k-ras DNA. As negative controls, serum samples from six patients with no detectable k-ras mutations in their disease tissues were subjected to DNA isolation and subsequently analyzed for k-ras mutations. Briefly, DNA from two aliquots of serum from each patient was isolated by the Qiagen method according to the manufacturer’s instructions or by the G/R method, as follows. Two volumes of 6 mol/L guanidine thiocyanate were mixed with the serum by inverting the mixture eight times. One milliliter of resin (from the Wizard DNA isolation reagent set; Promega) was then added, and the mixture was incubated for 2 h at room temperature with gentle mixing. The resin–DNA complex was transferred to a minicolumn (provided in the reagent set) and washed, and the DNA was eluted with H2O. Isolated DNA was quantified by real-time PCR on a LightCycler . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
H. Mamon, C. Hader, J. Li, L. Wang, M. Kulke, G. Amicarelli, E. Shehi, D. Adlerstein, K. Roper, L. Killion, et al.
Preferential Amplification of Apoptotic DNA from Plasma: Potential for Enhancing Detection of Minor DNA Alterations in Circulating DNA
Clin. Chem., September 1, 2008; 54(9): 1582 - 1584.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Muller, C. Beeger, C. Alix-Panabieres, X. Rebillard, K. Pantel, and H. Schwarzenbach
Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements
Clin. Chem., April 1, 2008; 54(4): 688 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Mora, E. Urgell, A. Farre, L. Comas, E. Montserrat, and F. Gonzalez-Sastre
Agreement between K-ras Sequence Variations Detected in Plasma and Tissue DNA in Pancreatic and Colorectal Cancer.
Clin. Chem., July 1, 2006; 52(7): 1448 - 1449.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Trombino, M. Neri, R. Puntoni, C. Angelini, M. Loprevite, A. Cesario, P. Granone, A. Imperatori, L. Dominioni, A. Ardizzoni, et al.
Mutations in K-ras Codon 12 Detected in Plasma DNA Are Not an Indicator of Disease in Patients with Non-Small Cell Lung Cancer
Clin. Chem., July 1, 2005; 51(7): 1313 - 1314.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.